ABG
TYRA icon

Ally Bridge Group’s Tyra Biosciences TYRA Stock Holding History

Ally Bridge Group’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-107,244
Closed -$997K – 36
2025
Q1 		$997K Sell
107,244
-67,819
-39% -$878K 0.9% 27
2024
Q4 		$2.43M Sell
175,063
-95,012
-35% -$1.72M 2.09% 23
2024
Q3 		$6.35M Buy
270,075
+5,415
+2% +$114K 3.4% 12
2024
Q2 		$4.23M Buy
+264,660
New +$4.56M 2.52% 20

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Ally Bridge Group's TYRA Position: Q2 2025 in Review

Ally Bridge Group sold out of Tyra Biosciences (TYRA) in Q2 2025, closing a stake of 107,244 shares — an estimated $997K sold.

Ally Bridge Group first reported a position in TYRA in Q2 2024 and held it in 4 quarters. The position peaked at $6.35M in Q3 2024. 121 funds tracked by Wall St. Rank hold TYRA as of Q2 2025.

  • Ally Bridge Group reported no remaining Tyra Biosciences position as of Q2 2025 after selling out during the quarter.
  • Ally Bridge Group sold 107,244 Tyra Biosciences shares in Q2 2025, an estimated $997K.
  • Ally Bridge Group first reported a position in Tyra Biosciences in Q2 2024 and held it in 4 quarters.
  • Ally Bridge Group's Tyra Biosciences position peaked at $6.35M in Q3 2024.
  • 121 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2025.

Based on Ally Bridge Group's 13F filing for Q2 2025, filed 14 Aug 2025.